Finance Home - My Yahoo - Yahoo! - Help

Monday, December 21, 2009, 12:23AM ET - U.S. Markets open in 9 hours and 7 minutes. Dow  0.20% Nasdaq  1.45%

CPEX Pharmaceuticals, Inc. (CPEX)

On Dec 18: 10.83   0.84 (7.20%)

MORE ON CPEX

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Competitors Get Competitors for:
DIRECT COMPETITOR COMPARISON   CPEX ALKS GSK MNKD Industry Market Cap: 27.53M 846.25M 105.96B 1.05B 123.26M Employ­ees: 18 570 99,003 580 181 Qtrly Rev Growth (yoy): 25.50% 1.80% 14.90% N/A 14.60% Revenue (ttm): 17.67M 295.19M 43.88B N/A 21.95M Gross Margin (ttm): 100.00% 84.83% 76.27% N/A 75.20% EBITDA (ttm): -1.60M 116.61M 17.30B -216.74M -1.65M Oper Margins (ttm): -12.89% 32.44% 34.30% N/A -18.10% Net Income (ttm): -2.25M 80.25M 7.88B -243.87M N/A EPS (ttm): -0.902 0.842 3.09 -2.351 N/A P/E (ttm): N/A 10.61 13.53 N/A 14.06 PEG (5 yr expected): N/A N/A 3.01 N/A 2.26 P/S (ttm): 1.68 2.83 2.42 N/A 3.62 ALKS = Alkermes, Inc. GSK = GlaxoSmithKline plc MNKD = MannKind Corp. Industry = Drug Manufacturers - Major BIOTECHNOLOGY COMPANIES RANKED BY SALES   Company Symbol Price Change Market Cap P/E Amgen Inc. AMGN 55.80 2.24% 56.48B 12.17 Genentech, Inc. Private - View Profile Biogen Idec Inc. BIIB 50.07 1.25% 14.48B 16.76 Genzyme Corp. GENZ 48.78 1.20% 12.95B 27.81 Merck Serono S.A. Private - View Profile Chiron Corporation Private - View Profile Gilead Sciences Inc. GILD 42.83 -0.86% 38.54B 16.56 MedImmune, Inc. Private - View Profile Life Technologies Corporation LIFE 51.28 0.81% 9.15B 1046.53 Teva Pharmaceutical Industries Limited TEVA 52.91 0.84% 46.61B 48.41 View Drug Manufacturers - Major Industry Center GENERIC DRUGMAKERS RANKED BY SALES   Company Symbol Price Change Market Cap P/E Sandoz International GmbH Private - View Profile Watson Pharmaceuticals Inc. WPI 38.09 0.42% 4.04B 19.63 King Pharmaceuticals Inc. KG 11.89 1.80% 2.95B N/A Ranbaxy Laboratories Limited Private - View Profile Mylan, Inc. MYL 18.25 -0.92% 5.58B 111.96 Pfizer Inc. PFE 18.30 0.44% 147.67B 15.20 Johnson & Johnson JNJ 64.37 -0.16% 177.60B 14.06 GlaxoSmithKline plc GSK 41.80 -0.36% 105.96B 13.53 Sanofi-Aventis SNY 39.11 1.90% 102.12B N/A Novartis AG NVS 54.21 0.58% 123.12B 16.23 View Drug Manufacturers - Major Industry Center DRUGMAKERS RANKED BY SALES   Company Symbol Price Change Market Cap P/E RHHBY.PK 41.95 0.70% N/A N/A AstraZeneca plc AZN 45.54 -0.11% 66.03B 9.14 Abbott Laboratories ABT 53.34 -0.45% 82.50B 14.45 Bristol-Myers Squibb Co. BMY 25.78 0.04% 51.07B 13.34 View Drug Manufacturers - Major Industry Center NEWS ON DIRECT COMPETITORS   • GSK Now Is the Time to Buy Risk Sat, Dec 19 - at Motley Fool • GSK Swine Flu Just Isn't Bringing Home the Bacon Fri, Dec 18 - at Motley Fool • GSK 3 Reasons to Sell Dendreon Today Fri, Dec 18 - at Motley Fool • GSK Celgene’s Surprising New Hope for Blood Cancer Fri, Dec 18 - at Minyanville.com • GSK Ligand, Glaxo drug closer to European approval Fri, Dec 18 - AP • ALKS Stock Watch: Beacon Equity Issues Market Alert for Alkermes Inc. Fri, Dec 18 - GlobeNewswire • ALKS Amylin Impresses in Head-to-Head Wed, Dec 16 - Zacks.com • MNKD The Best Investing Ideas in Health Care Wed, Dec 16 - at Motley Fool • ALKS UPDATE - Amylin reports positive data from Byetta study Tue, Dec 15 - at Reuters • ALKS Novo CEO Just Says "No" Tue, Dec 15 - at CNBC • ALKS Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study Tue, Dec 15 - PR Newswire • MNKD Biotech Calendar: Upcoming FDA Dates Tue, Dec 15 - at TheStreet.com • ALKS Finally Released From an Extended Review Mon, Dec 14 - at Motley Fool • ALKS Alkermes' Corporate Presentation to be Webcast at the Deutsche Bank Biotech Boston Confab Tue, Dec 8 - Business Wire • MNKD Rocket Stock or Dud? Tue, Dec 8 - at Motley Fool • MNKD Can This Stock Go Higher? Wed, Nov 18 - at Motley Fool • MNKD Merck's Dick Clark Has Opportunities, but All Are Risky Mon, Nov 16 - at The Wall Street Journal Online • MNKD This Drug Firm Will Snap Up 50% By Mid-2010: Trader Thu, Nov 12 - at CNBC • MNKD Mannkind Draws Bet on Big Upside Move Thu, Nov 12 - at TheStreet.com All Headlines for these symbols... Need more? Get unbiased, in-depth information on public and private companies worldwide from Hoover's Online.
Add to Portfolio     Set Alert     Email to a Friend Get Competitors for Another Symbol: Symbol Lookup • Stock Screener • Sector Analysis